BioLineRx Initiates Phase 2 Trial of a Stem Cell Mobilization Agent for Lymphoma Treatment – Lymphoma News Today
Lymphoma News TodayBioLineRx Initiates Phase 2 Trial of a Stem Cell Mobilization Agent for Lymphoma TreatmentLymphoma News TodayBioLineRx, Ltd., has announced the initiation of a Phase 2 trial of BL-8040 as a single agent to mobilize and collect bone m… Continue reading
